Workers are seen in cannabis company Organigram Global Inc.'s facility in Moncton, N.B., in this undated handout photo. THE CANADIAN PRESS/HANDOUT- Thiago De Oliveira Muniz - The Canadian PressTORONTO — Cannabis company Organigram Global Inc. says the acquisition of a European medical cannabis company has helped drive it to record quarterly revenues. Organigram says the April acquisition of German-based Sanity Group GmbH added about $38 million in net revenue during the three-month period that ended on June 30. This report by The Canadian Press was first published Aug. 12, 2026. Companies in this story: (TSX:OGI)The Canadian Press